NICE has implemented new measures to evaluate the cost-effectiveness of medicines, following a policy change that aims to give patients improved access to treatments.
People who have had a heart attack, stroke, or serious circulation problem in their legs, and who also carry excess weight, can now be offered a weekly injection to help protect them from a further ...
Public Health Minister Sharon Hodgson said: "Every woman with endometriosis deserves fertility care that recognises the complexity of her condition. This landmark guidance will ensure women can access ...
Learn how the MHRA and NICE are getting medicines to patients 3 to 6 months sooner by delivering same time decisions on ...
Surgical insertion of a catheter-based left ventricular microaxial flow pump for cardiogenic shock HTG774 25 March 2026 25 March 2026 Percutaneous insertion of a catheter-based left ventricular ...
Semaglutide for reducing the risk of major adverse cardiovascular events in people with cardiovascular disease and overweight or obesity [ID6441] ...
Tislelizumab with chemotherapy for untreated recurrent or metastatic nasopharyngeal cancer ID6304 Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and ...
Evidence-based recommendations on dupilumab (Dupixent) for add-on maintenance treatment of uncontrolled chronic obstructive pulmonary disease (COPD) with raised blood eosinophils in adults ...
This guidance updates and replaces NICE technology appraisal guidance on ruxolitinib cream for treating non-segmental vitiligo in people 12 years and over (TA1088). Next review: This guidance will be ...
Sophie Cooper, Senior Scientific Adviser, explains the importance of the recently published EQ-5D-5L value set and how it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results